title: Pharmaceutical approval update.
abstract: Cabozantinib (Cometriq) for metastatic medullary thyroid cancer; ponatinib (Iclusig) for two forms of leukemia; and raxibacumab for inhalational anthrax.
authors.forename: Marvin M
authors.initials: MM
authors.lastname: Goldenberg